Literature DB >> 3853465

Thermodynamics of anion binding to human serum transferrin.

W R Harris.   

Abstract

The binding of phosphate, bicarbonate, sulfate, and vanadate to human serum transferrin has been evaluated by two difference ultraviolet spectroscopic techniques. Direct titration of apotransferrin with bicarbonate, phosphate, and sulfate produces a strong negative absorbance near 245 nm, while titration with vanadate produces a positive absorbance in this region. Least-squares refinement of the absorbance data indicates that two anions of sulfate, phosphate, and vanadate bind to each transferrin molecule but that there is detectable binding of only a single bicarbonate anion. A second method used to study the thermodynamics of anion binding was competition equilibrium between anions for binding to the transferrin. The equilibrium constant for binding of the first equivalent of vanadate was determined by competition vs. phosphate and sulfate, while the equilibrium constant for binding of the second equivalent of bicarbonate was determined by competition vs. vanadate. Anion binding was described by two equilibrium constants for the successive binding of two anions per transferrin molecule: K1 = [A-Tr]/[A][Tr] and K2 = [A-Tr-A]/[A][A-Tr] where [A] represents the free anion concentration, [Tr] represents apotransferrin concentration, and [A-Tr] and [A-Tr-A] represent the concentrations of 1:1 and 2:1 anion-transferrin complexes, respectively. The results were the following: for phosphate, log K1 = 4.19 +/- 0.03 and log K2 = 3.25 +/- 0.21; for sulfate, log K1 = 3.62 +/- 0.07 and log K2 = 2.79 +/- 0.20; for vanadate, log K1 = 7.45 +/- 0.10 and log K2 = 6.6 +/- 0.30; for bicarbonate, log K1 = 2.66 +/- 0.07 and log K2 = 1.8 +/- 0.3.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3853465     DOI: 10.1021/bi00346a057

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

Review 1.  The long history of iron in the Universe and in health and disease.

Authors:  Alex D Sheftel; Anne B Mason; Prem Ponka
Journal:  Biochim Biophys Acta       Date:  2011-08-09

2.  Identification of a kinetically significant anion binding (KISAB) site in the N-lobe of human serum transferrin.

Authors:  Shaina L Byrne; Ashley N Steere; N Dennis Chasteen; Anne B Mason
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

3.  A perspective into ligand-receptor affinities using complex numbers.

Authors:  I M Klotz
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

4.  The chloride effect is related to anion binding in determining the rate of iron release from the human transferrin N-lobe.

Authors:  Q Y He; A B Mason; V Nguyen; R T MacGillivray; R C Woodworth
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

Review 5.  Kinetics of iron release from transferrin bound to the transferrin receptor at endosomal pH.

Authors:  Ashley N Steere; Shaina L Byrne; N Dennis Chasteen; Anne B Mason
Journal:  Biochim Biophys Acta       Date:  2011-06-15

6.  Anti-diabetic effects of a series of vanadium dipicolinate complexes in rats with streptozotocin-induced diabetes.

Authors:  Gail R Willsky; Lai-Har Chi; Michael Godzala; Paul J Kostyniak; Jason J Smee; Alejandro M Trujillo; Josephine A Alfano; Wenjin Ding; Zihua Hu; Debbie C Crans
Journal:  Coord Chem Rev       Date:  2011-10       Impact factor: 22.315

Review 7.  Transferrin-mediated cellular iron delivery.

Authors:  Ashley N Luck; Anne B Mason
Journal:  Curr Top Membr       Date:  2012       Impact factor: 3.049

8.  The unique kinetics of iron release from transferrin: the role of receptor, lobe-lobe interactions, and salt at endosomal pH.

Authors:  Shaina L Byrne; N Dennis Chasteen; Ashley N Steere; Anne B Mason
Journal:  J Mol Biol       Date:  2009-11-13       Impact factor: 5.469

Review 9.  Vanadium compounds in medicine.

Authors:  Joao Costa Pessoa; Susana Etcheverry; Dinorah Gambino
Journal:  Coord Chem Rev       Date:  2014-12-09       Impact factor: 22.315

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.